Anders D. Hove, Director, 10% Owner at Anacor Pharmaceuticals Inc (ANAC), bought 4,352,808 shares at $5.00 ($13.0M) on 2010-11-30, disclosed to the SEC on 2010-12-02.
Open-market purchase of $13.0M ANAC by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,752,808 | $0 | 0.0% |
| 2 | $5.00 | 600,000 | $3.0M | 23.1% |
| 3 | $5.00 | 2,000,000 | $10.0M | 76.9% |
| Total | $2.99 avg | 4,352,808 | $13.0M | 100% |
| Filing → |
| ANAC | SELL | 2015-12-17 | $100.1M | — | Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |
| ANAC | SELL | 2015-11-12 | $10.4M | — | Filing → |